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Escherichia coli aortic valve endocarditis
We read with interest the editorial in CMI by
Micol et al. [1] concerning Escherichia coli native
valve endocarditis (NVE). As described by the
authors, the number of reports of E. coli NVE has
increased in recent years and a further increase
may be expected in the future [1]. This is probably
a result of the changing demographical charac-
teristics of at-risk patients, and particularly the
increase in the number of elderly patients with
degenerative valvular lesions who present with
predisposing conditions for E. coli infections, e.g.,
altered vaginal mucosa in women, and higher
rates of diabetes mellitus, immunosuppressive
therapy and progressive cancer [1].
To add to this experience, we wish to describe a
further case of NVE caused by E. coli, according to
the modiﬁed Duke criteria [2], in a previously
healthy male, aged 73 years, who was diagnosed
with pancreatic adenocarcinoma. The patient
complained only of abdominal discomfort before
the diagnosis. After a diagnostic laparoscopy, the
lesion was considered to be unsuitable for surgi-
cal resection. During this period of hospitalisa-
tion, the patient was treated with intravenous
ciproﬂoxacin for a possible intra-abdominal infec-
tion. Chemotherapy was commenced with gem-
citabine. One week after starting chemotherapy
(6 weeks after the surgical procedure), the patient
presented with daily fever and prostration, fol-
lowed by an episode of bacteraemia, at which
point he was admitted to our hospital and a
diagnosis of NVE was made. This was conﬁrmed
on the basis of three separate blood cultures
yielding growth of E. coli, and a trans-oesopha-
geal echocardiography examination that showed
a bicuspid aortic valve with an adhering mass,
c. 0.9 cm in size, that was compatible with veget-
ation. The E. coli isolates were identiﬁed using
conventional microbiological methods, and sus-
ceptibility tests were performed according to
CLSI recommendations. The isolates were sus-
ceptible to all cephalosporins, including ﬁrst-
generation cephalosporins, but were resistant to
ciproﬂoxacin, trimethoprim-sulphamethoxazole
and ampicillin. A new systolic murmur had also
been noted in the week preceding hospitalisation.
Urine analysis was normal and urine culture was
negative. The patient was treated with intraven-
ous cefepime 2 g every 8 h for 4 weeks, followed
by 2 g every 12 h for an additional 2 weeks. After
2 weeks, the fever had resolved and the patient’s
general health improved signiﬁcantly. At the end
of treatment, the aortic lesions were still visual-
ised on trans-oesophageal echocardiography
examination, but the echogenicity suggested that
this represented an ‘endocarditis sequel’.
In contrast to most reported NVE patients, who
have been female and in whom urinary tract
infections were the most probable source of
bacteraemia [3], the patient described here was a
male without urinary tract disease. The probable
source of E. coli was the intestine. Whether the
surgical procedure contributed to bacteraemia is
uncertain, as other risk-factors, e.g., malignant
disease and chemotherapy, were also associated
with this patient. Despite the high mortality and
local complication rates described for E. coli NVE
[1,3], this patient showed a good response
following cefepime therapy for 6 weeks. In
summary, this report reinforces the role of E. coli
as a potential emerging cause of NVE in the
elderly population, and this diagnosis should be
considered for such patients, particularly in the
presence of persistent bacteraemia.
A. P. Zavascki1 and A. M. Morelle2
1Infectious Diseases Service and
2Oncology Service, Hospital Sa˜o Lucas da Pontifı´cia




1. Micol R, Lortholary O, Jaureguy F et al. Escherichia coli
native valve endocarditis. Clin Microbiol Infect 2006; 12: 401–
403.
2. Li JS, Sexton DJ, Mick N et al. Proposed modiﬁcations to the
Duke criteria for the diagnosis of infective endocarditis. Clin
Infect Dis 2000; 30: 633–638.
3. Branger S, Casalta JP, Habib G, Collard F, Raoult D.
Escherichia coli endocarditis: seven new cases in adults and
review of the literature. Eur J Clin Microbiol Infect Dis 2005;
24: 537–541.
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases
